SNHG9 and cancer: Moreover, the knockdown of SNHG9 in lung cancer cells increased the percentage of cells in the G1/G0 phase by more than 10%, whereas it reduced the percentage of S phase at least 10%, as compared with cancer cells without knockdown of SNHG9 (all p < 0.05) (Figure 1F).